Abstract:There is increasing data showing that angiotensin (Ang) II may be involve in the initiation and regulation of processes occurring in brain ischemia. Microvascular changes in the brain are notably the cause of cerebral edema and ischemia injury. we have recently shown Ang II injuries brain microvascular endothelial cells (BMECs) partly via regulation of intercellular adhesion molecule-1 (ICAM-1) expression. However, the signaling cascade leading to Ang II-induced ICAM-1 expression in BMECs had not been well elucidated. The transcription factor, nuclear factor-κB (NF-κB) is involved in the expression of several proinflammatory genes including cell adhesion molecules. The aim of the present study was to investigate the possible mechanism of Ang II regulating the expression of ICAM-1 in BMECs and evaluated the effect of a novel selective AT1 receptor antagonist EXP-2528. Cultured BCMECs were incubated with Ang II (10-7 mol/L) with or without the specific AT1 receptor inhibitor losartan (10-6 mol/L) and EXP-2528 (10-6 mol/L) and the specific AT2 receptor inhibitor PD 123,319 (10-6 mol/L) for indicated times. Total RNA, cytoplasmic and nuclear protein were extracted from different groups of cultured BMECs. RT-PCR was used to assess ICAM-1 mRNA expression, western blot analysis was used to assess ICAM-1 and IκBα protein expression. Nuclear extracts were used for western blot analysis of p65 protein expression and for electrophoretic mobility shift assay of NF-κB activity. Ang II directly stimulates ICAM-1 mRNA and protein expression in BMECs. Ang II treatment also resulted in the degradation of IκBα, an evident increasing of p65 subunit expression in the nucleus as well as the nuclear translocation of NF-κB. These effects were abolished by preincubation with the AT1-specific antagonist losartan or EXP-2528 or losartan plus the AT2 receptor antagonist PD123319 but not by PD123319 alone. Moreover, there were no significant difference between losartan group and losartan + PD 123,319 group. The present study demonstrates that Ang II upregulated ICAM-1 expression via NF-κB activation in BMECs by activating AT1 receptor, AT1 receptor antagonists, both EXP-2528 and losartan inhibit such effect of Ang II.

Angiotensin Ii Upregulates Endothelial Lipase Expression Via The Nf-Kappa B And Mapk Signaling Pathways

Endothelial Lipase is Upregulated by Interleukin-6 Partly Via the P38 MAPK and P65 NF-κB Signaling Pathways.

[Effects of Angiotensin II on Peripheral Blood Endothelial Progenitor Cells].

[Angiotensin II Increases the Expression of Lectin-Like Oxidize Low-Density Lipoprotein Receptor- 1 in Cultured Human Umbilical Vein Endothlial Cells]

Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration

Endothelial ELABELA improves post-ischemic angiogenesis by upregulating VEGFR2 expression

Regulated expression of endothelial lipase in atherosclerosis

Angiotensin II Up-Regulates Soluble Epoxide Hydrolase in Vascular Endothelium in Vitro and in Vivo.

Regulation of scavenger receptor class BI gene expression by angiotensin II in vascular endothelial cells.

Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells.

Angiotensin Ii Induces Vascular Cell Adhesion Molecule-1 Expression In Rat Vasculature - A Potential Link Between The Renin-Angiotensin System And Atherosclerosis

Angiotensin II up-regulates expression of inducible nitric oxide synthase in human umbilical endothelial cells: roles of AT1 and AT2]

DIFFERENT EFFECTS OF ANGIOTENSIN II AND ANGIOTENSIN-(1–7) ON ENDOTHELIAL VCAM-1 EXPRESSION DURING ATHEROSCLEROSIS

Angiotensin II Induces NF-κB Activation in HUVEC Via the P38mapk Pathway

EXP-2528, a Novel Angiotensin II Type 1 Receptor Antagonist, Protects Angiotensin II-stimulated Intercellular Adhesion Molecule-1 Via Nuclear Factor-Κb Activation in Brain Microvascular Endothelial Cells

Pi3k/Akt Signaling Pathway Plays A Role In Enhancement Of Enos Activity By Recombinant Human Angiotensin Converting Enzyme 2 In Human Umbilical Vein Endothelial Cells

Angiotensin-(1-7) Attenuates Angiotensin II-Induced ICAM-1, VCAM-1, and MCP-1 Expression via the MAS Receptor Through Suppression of P38 and NF-κB Pathways in HUVECs

Angiotensin II Upregulates Endothelin Receptors Through the Adenosine Monophosphate-Activated Protein Kinase/sirtuin 1 Pathway in Vascular Smooth Muscle Cells.

Angiotensin II Upregulates the Expression of Placental Growth Factor in Human Vascular Endothelial Cells and Smooth Muscle Cells

Chronic infusion of ELABELA alleviates vascular remodeling in spontaneously hypertensive rats via anti-inflammatory, anti-oxidative and anti-proliferative effects

ERK1/2 and SAPK/JNK signaling pathways mediate Ang II-induced rat vascular smooth muscle cells proliferation via monocyte chemoattractant protein-1 expression